Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Hyperandrogenism × Dexamethasone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 54 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Neoplasms, Plasma Cell 13 Recurrence 12 Leukemia 12 Vomiting 11 Lymphoma, Extranodal NK-T-Cell 10 Lymphoma 9 Neoplasms 8 Nausea 6 Lymphoma, Mantle-Cell 5 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, T-Cell, Peripheral 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Follicular 3 Lung Neoplasms 3 Carcinoma, Hepatocellular 3 Burkitt Lymphoma 3 Renal Insufficiency 2 Postoperative Nausea and Vomiting 2 Polycystic Ovary Syndrome 2 Paraproteinemias 2 Obesity 2 Neoplasms by Histologic Type 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphohistiocytosis, Hemophagocytic 2 Leukemia, T-Cell 2 Leukemia, Plasma Cell 2 Immunoglobulin Light-chain Amyloidosis 2 Hodgkin Disease 2

Interventions

Metformin 2 drospirenone and ethinyl estradiol combination 1 bicalutamide 1 Ultrasonography 1 Topiramate 1 Spironolactone 1 Progesterone 1 Ovidrel 1 Hematologic Tests 1 Ethinyl Estradiol 1 Dexamethasone 1 Cyproterone acetate, ethinyl estradiol drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01421810 2023-10-27

CBS001

University of Virginia

Phase NA Unknown

Obesity, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡